Report Overview
Report Overview
Biologics regulatory affairs outsourcing is a commercial service in which biologics companies entrust regulatory affairs-related work to external professional organizations. Biologics include complex pharmaceutical products such as vaccines, blood products, recombinant proteins, monoclonal antibodies, etc., and the research and development, production, sales and use of these products are subject to strict regulatory supervision. Regulatory affairs outsourcing involves ensuring that these biologics comply with relevant domestic and international regulatory requirements at all stages, including but not limited to clinical trial applications, drug registrations, license applications, quality standard formulation and maintenance, regulatory compliance supervision, etc.
The global Biologics Regulatory Affairs Outsourcing market size was estimated at USD 2023.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 9.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Biologics Regulatory Affairs Outsourcing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Biologics Regulatory Affairs Outsourcing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Biologics Regulatory Affairs Outsourcing market.
Global Biologics Regulatory Affairs Outsourcing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Lonza AG
Wuxi AppTec Inc.
Thermo Fisher Scientific Inc.
Eurofins Scientific SE
Freyr solutions
Catalent Inc.
Piramal Group
AGC Biologics
ICON Plc.
Charles River Laboratories International, Inc.
Labcorp
Parexel International
Medpace Holdings, Inc.
IQVIA
Syneos Health
SGS SA (SGS)
Market Segmentation (by Type)
Regulatory Consulting
Legal Representation
Regulatory Writing & Publishing
Product Registration
Regulatory Submissions
Regulatory Operations
Others
Market Segmentation (by Application)
Monoclonal Antibodies (mAbs)
Recombinant Proteins
Vaccines
Cell & Gene Therapies
Biosimilars
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biologics Regulatory Affairs Outsourcing Market
Overview of the regional outlook of the Biologics Regulatory Affairs Outsourcing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biologics Regulatory Affairs Outsourcing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biologics Regulatory Affairs Outsourcing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Biologics Regulatory Affairs Outsourcing
- 1.2 Key Market Segments
- 1.2.1 Biologics Regulatory Affairs Outsourcing Segment by Type
- 1.2.2 Biologics Regulatory Affairs Outsourcing Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Biologics Regulatory Affairs Outsourcing Market Overview
- 2.1 Global Market Overview
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Biologics Regulatory Affairs Outsourcing Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Biologics Regulatory Affairs Outsourcing Product Life Cycle
- 3.3 Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Company (2020-2025)
- 3.4 Biologics Regulatory Affairs Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.5 Headquarters, Areas Served, and Product Types of Major Players
- 3.6 Biologics Regulatory Affairs Outsourcing Market Competitive Situation and Trends
- 3.6.1 Biologics Regulatory Affairs Outsourcing Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Biologics Regulatory Affairs Outsourcing Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Biologics Regulatory Affairs Outsourcing Value Chain Analysis
- 4.1 Biologics Regulatory Affairs Outsourcing Value Chain Analysis
- 4.2 Midstream Market Analysis
- 4.3 Downstream Customer Analysis
- 5 The Development and Dynamics of Biologics Regulatory Affairs Outsourcing Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Biologics Regulatory Affairs Outsourcing Market Porters Five Forces Analysis
- 6 Biologics Regulatory Affairs Outsourcing Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Biologics Regulatory Affairs Outsourcing Market by Type (2020-2025)
- 6.3 Global Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Type (2021-2025)
- 7 Biologics Regulatory Affairs Outsourcing Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Biologics Regulatory Affairs Outsourcing Market Size (M USD) by Application (2020-2025)
- 7.3 Global Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Application (2021-2025)
- 8 Biologics Regulatory Affairs Outsourcing Market Segmentation by Region
- 8.1 Global Biologics Regulatory Affairs Outsourcing Market Size by Region
- 8.1.1 Global Biologics Regulatory Affairs Outsourcing Market Size by Region
- 8.1.2 Global Biologics Regulatory Affairs Outsourcing Market Size Market Share by Region
- 8.2 North America
- 8.2.1 North America Biologics Regulatory Affairs Outsourcing Market Size by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Biologics Regulatory Affairs Outsourcing Market Size by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Spain
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Biologics Regulatory Affairs Outsourcing Market Size by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Biologics Regulatory Affairs Outsourcing Market Size by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Biologics Regulatory Affairs Outsourcing Market Size by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 8.1 Global Biologics Regulatory Affairs Outsourcing Market Size by Region
- 9 Key Companies Profile
- 9.1 Lonza AG
- 9.1.1 Lonza AG Basic Information
- 9.1.2 Lonza AG Biologics Regulatory Affairs Outsourcing Product Overview
- 9.1.3 Lonza AG Biologics Regulatory Affairs Outsourcing Product Market Performance
- 9.1.4 Lonza AG SWOT Analysis
- 9.1.5 Lonza AG Business Overview
- 9.1.6 Lonza AG Recent Developments
- 9.2 Wuxi AppTec Inc.
- 9.2.1 Wuxi AppTec Inc. Basic Information
- 9.2.2 Wuxi AppTec Inc. Biologics Regulatory Affairs Outsourcing Product Overview
- 9.2.3 Wuxi AppTec Inc. Biologics Regulatory Affairs Outsourcing Product Market Performance
- 9.2.4 Wuxi AppTec Inc. SWOT Analysis
- 9.2.5 Wuxi AppTec Inc. Business Overview
- 9.2.6 Wuxi AppTec Inc. Recent Developments
- 9.3 Thermo Fisher Scientific Inc.
- 9.3.1 Thermo Fisher Scientific Inc. Basic Information
- 9.3.2 Thermo Fisher Scientific Inc. Biologics Regulatory Affairs Outsourcing Product Overview
- 9.3.3 Thermo Fisher Scientific Inc. Biologics Regulatory Affairs Outsourcing Product Market Performance
- 9.3.4 Thermo Fisher Scientific Inc. SWOT Analysis
- 9.3.5 Thermo Fisher Scientific Inc. Business Overview
- 9.3.6 Thermo Fisher Scientific Inc. Recent Developments
- 9.4 Eurofins Scientific SE
- 9.4.1 Eurofins Scientific SE Basic Information
- 9.4.2 Eurofins Scientific SE Biologics Regulatory Affairs Outsourcing Product Overview
- 9.4.3 Eurofins Scientific SE Biologics Regulatory Affairs Outsourcing Product Market Performance
- 9.4.4 Eurofins Scientific SE Business Overview
- 9.4.5 Eurofins Scientific SE Recent Developments
- 9.5 Freyr solutions
- 9.5.1 Freyr solutions Basic Information
- 9.5.2 Freyr solutions Biologics Regulatory Affairs Outsourcing Product Overview
- 9.5.3 Freyr solutions Biologics Regulatory Affairs Outsourcing Product Market Performance
- 9.5.4 Freyr solutions Business Overview
- 9.5.5 Freyr solutions Recent Developments
- 9.6 Catalent Inc.
- 9.6.1 Catalent Inc. Basic Information
- 9.6.2 Catalent Inc. Biologics Regulatory Affairs Outsourcing Product Overview
- 9.6.3 Catalent Inc. Biologics Regulatory Affairs Outsourcing Product Market Performance
- 9.6.4 Catalent Inc. Business Overview
- 9.6.5 Catalent Inc. Recent Developments
- 9.7 Piramal Group
- 9.7.1 Piramal Group Basic Information
- 9.7.2 Piramal Group Biologics Regulatory Affairs Outsourcing Product Overview
- 9.7.3 Piramal Group Biologics Regulatory Affairs Outsourcing Product Market Performance
- 9.7.4 Piramal Group Business Overview
- 9.7.5 Piramal Group Recent Developments
- 9.8 AGC Biologics
- 9.8.1 AGC Biologics Basic Information
- 9.8.2 AGC Biologics Biologics Regulatory Affairs Outsourcing Product Overview
- 9.8.3 AGC Biologics Biologics Regulatory Affairs Outsourcing Product Market Performance
- 9.8.4 AGC Biologics Business Overview
- 9.8.5 AGC Biologics Recent Developments
- 9.9 ICON Plc.
- 9.9.1 ICON Plc. Basic Information
- 9.9.2 ICON Plc. Biologics Regulatory Affairs Outsourcing Product Overview
- 9.9.3 ICON Plc. Biologics Regulatory Affairs Outsourcing Product Market Performance
- 9.9.4 ICON Plc. Business Overview
- 9.9.5 ICON Plc. Recent Developments
- 9.10 Charles River Laboratories International, Inc.
- 9.10.1 Charles River Laboratories International, Inc. Basic Information
- 9.10.2 Charles River Laboratories International, Inc. Biologics Regulatory Affairs Outsourcing Product Overview
- 9.10.3 Charles River Laboratories International, Inc. Biologics Regulatory Affairs Outsourcing Product Market Performance
- 9.10.4 Charles River Laboratories International, Inc. Business Overview
- 9.10.5 Charles River Laboratories International, Inc. Recent Developments
- 9.11 Labcorp
- 9.11.1 Labcorp Basic Information
- 9.11.2 Labcorp Biologics Regulatory Affairs Outsourcing Product Overview
- 9.11.3 Labcorp Biologics Regulatory Affairs Outsourcing Product Market Performance
- 9.11.4 Labcorp Business Overview
- 9.11.5 Labcorp Recent Developments
- 9.12 Parexel International
- 9.12.1 Parexel International Basic Information
- 9.12.2 Parexel International Biologics Regulatory Affairs Outsourcing Product Overview
- 9.12.3 Parexel International Biologics Regulatory Affairs Outsourcing Product Market Performance
- 9.12.4 Parexel International Business Overview
- 9.12.5 Parexel International Recent Developments
- 9.13 Medpace Holdings, Inc.
- 9.13.1 Medpace Holdings, Inc. Basic Information
- 9.13.2 Medpace Holdings, Inc. Biologics Regulatory Affairs Outsourcing Product Overview
- 9.13.3 Medpace Holdings, Inc. Biologics Regulatory Affairs Outsourcing Product Market Performance
- 9.13.4 Medpace Holdings, Inc. Business Overview
- 9.13.5 Medpace Holdings, Inc. Recent Developments
- 9.14 IQVIA
- 9.14.1 IQVIA Basic Information
- 9.14.2 IQVIA Biologics Regulatory Affairs Outsourcing Product Overview
- 9.14.3 IQVIA Biologics Regulatory Affairs Outsourcing Product Market Performance
- 9.14.4 IQVIA Business Overview
- 9.14.5 IQVIA Recent Developments
- 9.15 Syneos Health
- 9.15.1 Syneos Health Basic Information
- 9.15.2 Syneos Health Biologics Regulatory Affairs Outsourcing Product Overview
- 9.15.3 Syneos Health Biologics Regulatory Affairs Outsourcing Product Market Performance
- 9.15.4 Syneos Health Business Overview
- 9.15.5 Syneos Health Recent Developments
- 9.16 SGS SA (SGS)
- 9.16.1 SGS SA (SGS) Basic Information
- 9.16.2 SGS SA (SGS) Biologics Regulatory Affairs Outsourcing Product Overview
- 9.16.3 SGS SA (SGS) Biologics Regulatory Affairs Outsourcing Product Market Performance
- 9.16.4 SGS SA (SGS) Business Overview
- 9.16.5 SGS SA (SGS) Recent Developments
- 9.1 Lonza AG
- 10 Biologics Regulatory Affairs Outsourcing Market Forecast by Region
- 10.1 Global Biologics Regulatory Affairs Outsourcing Market Size Forecast
- 10.2 Global Biologics Regulatory Affairs Outsourcing Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Biologics Regulatory Affairs Outsourcing Market Size Forecast by Country
- 10.2.3 Asia Pacific Biologics Regulatory Affairs Outsourcing Market Size Forecast by Region
- 10.2.4 South America Biologics Regulatory Affairs Outsourcing Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Sales of Biologics Regulatory Affairs Outsourcing by Country
- 11 Forecast Market by Type and by Application (2026-2035)
- 11.1 Global Biologics Regulatory Affairs Outsourcing Market Forecast by Type (2026-2035)
- 11.1.1 Global Biologics Regulatory Affairs Outsourcing Market Size Forecast by Type (2026-2035)
- 11.2 Global Biologics Regulatory Affairs Outsourcing Market Forecast by Application (2026-2035)
- 11.2.1 Global Biologics Regulatory Affairs Outsourcing Market Size (M USD) Forecast by Application (2026-2035)
- 11.1 Global Biologics Regulatory Affairs Outsourcing Market Forecast by Type (2026-2035)
- 12 Conclusion and Key Findings